In recent developments, over 50 scientific societies have voiced their opposition to a recent executive order by the Trump administration. This order, which aims to exert political control over grant funding for federally supported research, has raised significant concerns among the scientific community. The affected organizations have issued a collective letter to the U.S. Congress, urging lawmakers to safeguard the integrity of the established merit-based, peer-review system for federal grants.
The executive order, announced last month, mandates that any announcements of funding opportunities must receive approval from agency heads or their designated appointees. This effectively places political appointees in pivotal roles for deciding which scientific disciplines receive funding. Further stipulations in the order could allow these appointees to cancel previously awarded grants if deemed not in alignment with agency priorities. The order’s provisions stipulate that new funding programs cannot commence until the system is fully implemented, potentially stalling scientific progress.
The coalition of scientific and medical organizations opposing the order includes some of the most prominent voices in research, collectively expressing concern over the politicization of science ([Ars Technica](https://arstechnica.com/science/2025/09/50-scientific-societies-sign-letter-objecting-to-trump-executive-order/), opens in a new tab). These organizations argue that such political oversight has the potential to undermine scientific innovation and progress by prioritizing political agendas over scientific merit.
This isn’t the first time that funding processes have become a contentious topic. Similar concerns have been raised in the past about how political influence can sway scientific endeavors and research priorities. The current situation accentuates the ongoing debate about the balance between government oversight and the autonomy of scientific exploration.
As the scientific community rallies to protect its independence, the outcome of this situation will be closely watched by legal professionals and corporations, especially those heavily invested in research and development. The response by Congress will likely set precedents for how scientific research is funded and managed in the coming years.